- £875.56m
- £1.24bn
- €3.07bn
2024 Preliminary Results
UK Stocks-Factors to watch on February 25
Berenberg predicts 'another eventful year' for MedTech sector
Brief: Uniphar Sees Double Digit Organic Gross Profit Growth In 2025 For Uniphar Pharma
Full Year Trading Update and Notice of Results
Holding(s) in Company
Director/PDMR Shareholding
Holding(s) in Company
Brief: Uniphar Sees FY Organic Gross Profit Growth Across All Divisions In Line With Medium-Term Targets
2024 Interim Results
Brief: Uniphar Remains Focused On Reaching EUR 200 Mln EBITDA In Medium Term
Half Year Trading Update and Notice of Results
Holding(s) in Company
Director/PDMR Shareholding
Holding(s) in Company
Brief: Uniphar Says Performance In First Four Months In Line With Board's Expectations
AGM Statement
Holding(s) in Company
Director/PDMR Shareholding